The EC has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsychotic, Rxulti (brexpiprazole), for treating ...

February saw several changes on boards at biotechs, bringing a diverse wealth of experience to support these companies. Read ...

Melt&Marble, a company specializing in precision-fermented fats, has announced two significant additions to its leadership ...

The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple ...

Melt&Marble, a developer of precision fermented fats used in meat analogues, has appointed biotech veteran Tue Hodal as its ...

Arizona legislative committee approves a modified bill to fund Chase Field repairs with a public cap of $500 million.

Four executions are scheduled this year with a new lethal injection protocol and the ethical and legal debate is intensifying ...

The European Commission (EC) has approved Danish CNS specialist Lundbeck (LUND: CO) and Otsuka Europe’s Rxulti (brexpiprazole) for the treatment of schizophrenia in adolescents aged 13 years and ...

HB 2704 passed the house last month and was in front of the Senate Finance Committee on Monday where it narrowly passed.

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Tennessee has paid nearly $600,000 for lethal injection drugs in recent years, but the details are shrouded in secrecy.